Vidal C, Hoffmeister L, Biagini L: Tendencia de la mortalidad por cancer de cuello uterino en Chile: aplicacion de modelos de regresion joinpoint. Rev Panam Salud Publica. 2013, 33 (6): 407-413.
PubMed
Google Scholar
Ministerio de Salud de Chile. Departamento de Estadisticas e Informacion de Salud: Serie de mortalidad observada y ajustada por tumores malignos, Chile 2000-2011 (Accessed July 2014). [http://www.deis.cl/wp-content/uploads/2014/04/Def_Mort_obs_ajust_tumores_Region_2000-2011.xlsx]
Arbyn M, Castellsague X, de Sanjose S, Bruni L, Saraiya M, Bray F, Ferlay J: Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011, 22 (12): 2675-2686.
Article
CAS
PubMed
Google Scholar
Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, Naghavi M: Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011, 378 (9801): 1461-1484.
Article
PubMed
Google Scholar
Ferreccio C, Barriga MI, Lagos M, Ibanez C, Poggi H, Gonzalez F, Terrazas S, Katki HA, Nuñez F, Cartagena J, Van De Wyngard V, Viñales D, Brañes J: Screening trial of human papillomavirus for early detection of cervical cancer in Santiago, Chile. Int J Cancer. 2013, 132 (4): 916-923.
Article
CAS
PubMed
Google Scholar
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Muñoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189 (1): 12-19.
Article
CAS
PubMed
Google Scholar
Ferreccio C, Corvalan A, Margozzini P, Viviani P, Gonzalez C, Aguilera X, Gravitt PE: Baseline assessment of prevalence and geographical distribution of HPV types in Chile using self-collected vaginal samples. BMC Public Health. 2008, 8: 78-
Article
PubMed
PubMed Central
Google Scholar
Ferreccio C, Van De Wyngard V, Olcay F, Dominguez MA, Puschel K, Corvalan AH, Franceschi S, Snijders PJF: High-risk HPV infection after five years in a population-based cohort of Chilean women. Infect Agents Cancer. 2011, 6 (1): 21-
Article
PubMed
PubMed Central
Google Scholar
Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998, 338 (7): 423-428.
Article
CAS
PubMed
Google Scholar
Viscidi RP, Schiffman M, Hildesheim A, Herrero R, Castle PE, Bratti MC, Rodriguez AC, Sherman ME, Wang S, Clayman B, Burk RD: Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica. Cancer Epidemiol Biomarkers Prev. 2004, 13 (2): 324-327.
Article
PubMed
Google Scholar
Wang SS, Schiffman M, Shields TS, Herrero R, Hildesheim A, Bratti MC, Sherman ME, Rodriguez AC, Castle PE, Morales J, Alfaro M, Wright T, Chen S, Clayman B, Burk RD, Viscidi RP: Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10000 women in Costa Rica. Br J Cancer. 2003, 89 (7): 1248-1254.
Article
CAS
PubMed
PubMed Central
Google Scholar
Clifford GM, Shin HR, Oh JK, Waterboer T, Ju YH, Vaccarella S, Quint W, Pawlita M, Franceschi S: Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea. Cancer Epidemiol Biomarkers Prev. 2007, 16 (9): 1874-1879.
Article
CAS
PubMed
Google Scholar
Ho GY, Studentsov YY, Bierman R, Burk RD: Natural history of human papillomavirus type 16 virus-like particle antibodies in young women. Cancer Epidemiol Biomarkers Prev. 2004, 13 (1): 110-116.
Article
CAS
PubMed
Google Scholar
Robbins HA, Li Y, Porras C, Pawlita M, Ghosh A, Rodriguez AC, Schiffman M, Wacholder S, Kemp TJ, Gonzalez P, Schiller J, Lowy D, Esser M, Matys K, Quint W, van Doorn LJ, Herrero R, Pinto LA, Hildesheim A, Waterboer T, Safaeian M: Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus. BMC Infect Dis. 2014, 14: 120-
Article
PubMed
PubMed Central
Google Scholar
World Health Organization: Meeting of the Strategic Advisory Group of Experts on immunization, April 2014 – conclusions and recommendations. Wkly Epidemiol Rec. 2014, 89: 221-236.
Google Scholar
Ferreccio C, Prado RB, Luzoro AV, Ampuero SL, Snijders PJ, Meijer CJ, Vaccarella SV, Jara AT, Puschel KI, Robles SC, Herrero R, Franceschi SF, Ojeda JM: Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev. 2004, 13 (12): 2271-2276.
PubMed
Google Scholar
Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S: Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Brit J Cancer. 2003, 88: 63-73.
Article
CAS
PubMed
PubMed Central
Google Scholar
Roa JC, Garcia P, Gomez J, Fernandez W, Gaete F, Espinoza A, Lepetic A, Suarez E: HPV genotyping from invasive cervical cancer in Chile. Int J Gynecol Obstet. 2009, 105: 150-153.
Article
Google Scholar
Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, Joos TO, Templin MF, Pawlita M: Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem. 2005, 51: 1845-1853.
Article
CAS
PubMed
Google Scholar
Waterboer T, Neale R, Michael KM, Sehr P, de Koning MN, Weissenborn SJ, Sampogna F, Abeni D, Green AC, Bavinck JNB, Pawlita M, EPI-HPV-UV-CA Group: Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia. J Gen Virol. 2009, 90 (8): 1986-1998.
Article
CAS
PubMed
Google Scholar
Dondog B, Clifford GM, Vaccarella S, Waterboer T, Unurjargal D, Avirmed D, Enkhtuya S, Kommoss F, Wentzensen N, Snijders PJF, Meijer CJLM, Franceschi S, Pawlita M: Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study. Cancer Epidemiol Biomarkers Prev. 2008, 17 (7): 731-738.
Article
Google Scholar
Hardin JW, Hilbe JM: Chapter 3. Generalized Estimating Equations. 2003, Boca Raton, FL: Chapman & Hall
Google Scholar
Silins I, Kallings I, Dillner J: Correlates of the spread of human papillomavirus infection. Cancer Epidemiol Biomarkers Prev. 2000, 9 (9): 953-959.
CAS
PubMed
Google Scholar
Wang IJ, Viscidi R, Hwang KC, Lin TY, Chen CJ, Huang LM, Chen HH, Chen CJ: Seroprevalence and risk factors for human papillomavirus in Taiwan. J Trop Pediatrics. 2008, 54 (1): 14-18.
Article
CAS
Google Scholar
Smith JS, Lewkowitz AK, Qiao YL, Ji J, Hu S, Chen W, Zhang R, Liaw KL, Esser M, Taddeo FJ, Pretorius RG, Belinson JL: Population-based human papillomavirus 16, 18, 6 and 11 DNA positivity and seropositivity in Chinese women. Int J Cancer. 2012, 131 (6): 1388-1395.
Article
CAS
PubMed
PubMed Central
Google Scholar
Desai S, Chapman R, Jit M, Nichols T, Borrow R, Wilding M, Linford C, Lowndes C, Nardone A, Pebody R, Soldan K: Prevalence of human papillomavirus antibodies in males and females in England. Sex Transm Dis. 2011, 38 (7): 622-629.
Article
CAS
PubMed
Google Scholar
Markowitz LE, Sternberg M, Dunne EF, McQuillan G, Unger ER: Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004. J Infect Dis. 2009, 200 (7): 1059-1067.
Article
PubMed
Google Scholar
Wilson LE, Pawlita M, Castle PE, Waterboer T, Sahasrabuddhe V, Gravitt PE, Schiffman M, Wentzensen N: Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study. Int J Cancer. 2013, 133 (9): 2172-2181.
Article
CAS
PubMed
PubMed Central
Google Scholar
Scherpenisse M, Mollers M, Schepp RM, Boot HJ, de Melker HE, Meijer CJLM, Berbers GAM, van der Klis FRM: Seroprevalence of seven high-risk HPV types in The Netherlands. Vaccine. 2012, 30 (47): 6686-6693.
Article
PubMed
Google Scholar
Newall AT, Brotherton JM, Quinn HE, McIntyre PB, Backhouse J, Gilbert L, Esser MT, Erick J, Bryan J, Formica N, MacIntyre CR: Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia. Clin Infect Dis. 2008, 46 (11): 1647-1655.
Article
PubMed
Google Scholar
Franceschi S, Herrero R, Clifford GM, Snijders PJ, Arslan A, Anh PT, Bosch FX, Ferreccio C, Hieu NT, Lazcano-Ponce E, Matos E, Molano M, Qiao YL, Rajkumar R, Ronco G, de Sanjose S, Shin HR, Sukvirach S, Thomas JO, Meijer CJLM, Muñoz N, IARC HPV Prevalence Surveys Study Group: Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer. 2006, 119 (11): 2677-2684.
Article
CAS
PubMed
Google Scholar
Bedoya AM, Gaviria AM, Baena A, Borrero M, Duarte DF, Combita AL, Castaño J, Grisales H, Sanchez G: Age-specific seroprevalence of human papillomavirus 16, 18, 31, and 58 in women of a rural town of Colombia. Int J Gynecol Cancer. 2012, 22 (2): 303-310.
Article
PubMed
Google Scholar
Ji J, Sun HK, Smith JS, Wang H, Esser MT, Hu S, Pretorius RG, Chen W, Belinson JL, Qiao YL: Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women. BMC Infect Dis. 2012, 12: 137-
Article
PubMed
PubMed Central
Google Scholar
Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N, Galloway DA: Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis. 2000, 181 (6): 1911-1919.
Article
CAS
PubMed
Google Scholar
Steele J, Collins S, Wen K, Ryan G, Constandinou-Williams C, Woodman CB: Measurement of the humoral immune response following an incident human papillomavirus type 16 or 18 infection in young women by a pseudovirion-based neutralizing antibody assay. Clin Vaccine Immunol. 2008, 15 (9): 1387-1390.
Article
CAS
PubMed
PubMed Central
Google Scholar
Syrjänen S, Waterboer T, Sarkola M, Michael K, Rintala M, Syrjänen K, Grenman S, Pawlita M: Dynamics of human papillomavirus serology in women followed up for 36 months after pregnancy. J Gen Virol. 2009, 90: 1515-1526.
Article
PubMed
Google Scholar
Wang SS, Schiffman M, Herrero R, Carreon J, Hildesheim A, Rodriguez AC, Bratti MC, Sherman ME, Morales J, Guillen D, Alfaro M, Clayman B, Burk RD, Viscidi RP: Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica. Br J Cancer. 2004, 91 (7): 1269-1274.
Article
CAS
PubMed
PubMed Central
Google Scholar
Malik ZA, Hailpern SM, Burk RD: Persistent antibodies to HPV virus-like particles following natural infection are protective against subsequent cervicovaginal infection with related and unrelated HPV. Viral Immunol. 2009, 22 (6): 445-449.
Article
CAS
PubMed
PubMed Central
Google Scholar